title: Ultraviolet B radiation differentially modifies catechol-O-methyltransferase activity in keratinocytes and melanoma cells.
abstract: BACKGROUND
  Catechol-O-methyltransferase (COMT) is a ubiquitous enzyme inactivating catecholic compounds. COMT is expressed also in human skin samples, and in melanoma cells it may be cytoprotective. A role of COMT in keratinocytes (HaCat) is unknown.
  
  
  OBJECTIVE
  The objective of this study is: to investigate whether ultraviolet-B (UVB) radiation modifies COMT activity in melanocytes and HaCat and whether COMT inhibition plays a role in UVB-induced cell death.
  
  
  METHODS
  Human cell lines of melanotic melanoma (SK-mel-1) and HaCat were used. COMT activity was evaluated under basal conditions and after UVB irradiation (311 nm) at a low (8 mJ/cm(2)) and a high dose (60 mJ/cm(2)). Tolcapone 1 μM was used to inhibit COMT.
  
  
  RESULTS
  Both SK-mel-1 and Ha-Cat cells express COMT activity. In SK-mel-1, COMT activity is reduced nearly 50% both 24 h and 48 h after a high dose UVB. In Ha-Cat cells, COMT activity increased 24 h after a high dose UVB but decreased at 48 h. Tolcapone increases significantly the cytotoxic effect of high dose UVB irradiation only in HaCat. High concentrations of tolcapone reduced melanin levels in melanoma cells parallel to reduced cell numbers.
  
  
  CONCLUSIONS
  Ultraviolet radiation differentially modifies COMT activity in melanoma cells and HaCat. Furthermore, tolcapone increased death of HaCat after irradiation but did not affect melanoma cells.
authors.affiliation: Institute of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal. smagina@med.up.pt
authors.forename: Sofia
authors.initials: S
authors.lastname: Magina
authors.forename: Maria Augusta
authors.initials: MA
authors.lastname: Vieira-Coelho
authors.forename: Maria Paula
authors.initials: MP
authors.lastname: Serrão
authors.forename: Carina
authors.initials: C
authors.lastname: Kosmus
authors.forename: Eduardo
authors.initials: E
authors.lastname: Moura
authors.forename: Daniel
authors.initials: D
authors.lastname: Moura
mesh_terms: D001577:Benzophenones / Q000494:pharmacology; D002394:Catechol O-Methyltransferase / Q000378:metabolism*; D065098:Catechol O-Methyltransferase Inhibitors; D016923:Cell Death / Q000187:drug effects / Q000528:radiation effects; D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D015603:Keratinocytes / Q000201:enzymology* / Q000473:pathology; D008545:Melanoma / Q000201:enzymology* / Q000473:pathology; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009596:Nitrophenols / Q000494:pharmacology; D000077867:Tolcapone; D014466:Ultraviolet Rays
chemical_list: D001577:Benzophenones; D065098:Catechol O-Methyltransferase Inhibitors; D004791:Enzyme Inhibitors; D009363:Neoplasm Proteins; D009596:Nitrophenols; D000077867:Tolcapone; D002394:Catechol O-Methyltransferase